473 filings
Page 2 of 24
4
re03a uae9
1 Jul 20
VistaGen Therapeutics / H. RALPH SNODGRASS ownership change
5:35pm
4
3q3fa4 y2r58iz
1 Jul 20
VistaGen Therapeutics / Mark Alan Smith ownership change
5:33pm
4
jyqj1q ymza554em
1 Jul 20
VistaGen Therapeutics / JERROLD DUANE DOTSON ownership change
5:28pm
4
3utohg
1 Jul 20
VistaGen Therapeutics / Shawn Singh ownership change
5:20pm
8-K
smv96dtmg
30 Jun 20
VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update
4:16pm
8-K
nuqaaks13
26 Jun 20
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
5:27pm
8-K
tfqqo
1 Jun 20
VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
4:53pm
8-K
1vl s2hquuc7ip
18 May 20
The Proposed Phase 2A Open-label Study will be Conducted in New York City
5:15pm
424B3
h1fmd6d
15 May 20
Prospectus supplement
4:34pm
EFFECT
y165 guelpot
14 May 20
Notice of effectiveness
12:15am
CORRESP
shcnyp
8 May 20
Correspondence with SEC
12:00am
UPLOAD
7l8y3n
7 May 20
Letter from SEC
12:00am
8-K
f3uusnkgwzpd1
28 Apr 20
VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19
4:32pm
8-K
3rmcjep
27 Apr 20
Entry into a Material Definitive Agreement
5:16pm
4
yj53tttu g2j6v8exf
27 Apr 20
VistaGen Therapeutics / MARK A. MCPARTLAND ownership change
5:11pm
4
gqs1 qox7pb
27 Apr 20
VistaGen Therapeutics / JERROLD DUANE DOTSON ownership change
5:10pm
4
syqa4y5a
27 Apr 20
VistaGen Therapeutics / Mark Alan Smith ownership change
5:10pm